"A study of over 1 million US veterans found that updated COVID-19 vaccines reduce the risk of major adverse cardiovascular events (MACE). Vaccine effectiveness against MACE was estimated at 38 percent. Benefits were most pronounced in individuals aged 75 and older and those with underlying health conditions."